First author (year) | CRT intervention | Concordance of LV lead to latest site of activation, % | OR for CRT response (95 % CI) | CRT response, count (%) | LVESV (ml), mean ± SD | Change from baseline | LVEF (%), mean ± SD | All-cause mortality, count (%) | HF-related hospitalization, count (%) | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Baseline | Post treatment | Baseline | Post treatment | Change from baseline | ||||||||
Saba (2013) [43] | Image-guided | Exact/adjacent: | NR | 50 (57 %) | 140 ± 59 | NR | −30 ± 29 (%)a | 26 ± 6 | 38 ± 12.8b | 12 ± 11 | 15 (13.6 %) | 16 (14.5 %) |
30/NR | ||||||||||||
Exact or adjacent: 85 | ||||||||||||
Remote: 15 | ||||||||||||
Standard | Exact/adjacent: | 22 (35 %) | 144 ± 63 | NR | −20 ± 25 (%)a | 26 ± 7 | 35 ± 11.45b | 9 ± 10 | 15 (19.5 %) | 21 (27.3 %) | ||
12/NR | ||||||||||||
Exact or adjacent: 66 | ||||||||||||
Remote: 33 | ||||||||||||
Khan (2012) [42] | Image-guided | Exact/adjacent: | 1.92 (1.08, 3.39) | 72 (70 %) | 157 ± 56 | 111 ± 43 | −46 ± 33 (ml) | 23 ± 6 | 31 ± 9 | 8 ± 7 | 22 (10 %) | 18 (8 %) |
63/26 | ||||||||||||
Exact or adjacent: NR | ||||||||||||
Remote: 10 | ||||||||||||
Standard | Exact/adjacent: | 1.0 (reference) | 57 (55 %) | 154 ± 52 | 128 ± 50 | −26 ± 23 (ml) | 23 ± 7 | 28 ± 10 | 5 ± 8 |  | ||
47/29 | ||||||||||||
Exact or adjacent: NR | ||||||||||||
Remote: 25 | ||||||||||||
Bai (2011) [44] | Image-guided | NR | 2.68 (1.08-6.65)c | 41 (82 %) | 172 ± 65 | 129 ± 65 | −43 ± 65 (ml) | 23 ± 7 | 34 ± 10 | 11 ± 8.89d | NR | NR |
Standard | NR | 1.0 (reference) | 34 (63 %) | 159 ± 74 | 141 ± 82 | −18 ± 78 (ml) | 26 ± 6 | 32 ± 9 | 6 ± 7.94d | NR | NR |